India · Delayed Price · Currency is INR Marinus Pharmaceuticals Statistics
Total Valuation
BOM:532734 has a market cap or net worth of INR 121.54 billion. The enterprise value is 118.00 billion.
| Market Cap | 121.54B |
| Enterprise Value | 118.00B |
Important Dates
The next estimated earnings date is Tuesday, August 12, 2025.
| Earnings Date | Aug 12, 2025 |
| Ex-Dividend Date | Aug 14, 2025 |
Share Statistics
| Current Share Class | 646.90M |
| Shares Outstanding | n/a |
| Shares Change (YoY) | -1.69% |
| Shares Change (QoQ) | -0.11% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 209.43M |
Valuation Ratios
The trailing PE ratio is 16.40 and the forward PE ratio is 11.59.
| PE Ratio | 16.40 |
| Forward PE | 11.59 |
| PS Ratio | 2.27 |
| PB Ratio | 2.46 |
| P/TBV Ratio | 2.52 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 15.92 |
| EV / Sales | 2.21 |
| EV / EBITDA | 10.59 |
| EV / EBIT | 12.36 |
| EV / FCF | n/a |
Financial Position
| Current Ratio | n/a |
| Quick Ratio | n/a |
| Debt / Equity | 0.06 |
| Debt / EBITDA | 0.28 |
| Debt / FCF | n/a |
| Interest Coverage | 16.69 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | 11.95% |
| Return on Capital Employed (ROCE) | n/a |
| Revenue Per Employee | 17.86M |
| Profits Per Employee | 2.47M |
| Employee Count | 2,995 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, BOM:532734 has paid 2.53 billion in taxes.
| Income Tax | 2.53B |
| Effective Tax Rate | 25.39% |
Stock Price Statistics
The stock price has decreased by -18.32% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | -18.32% |
| 50-Day Moving Average | 187.84 |
| 200-Day Moving Average | 189.88 |
| Relative Strength Index (RSI) | 46.42 |
| Average Volume (20 Days) | 136,058 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, BOM:532734 had revenue of INR 53.49 billion and earned 7.41 billion in profits. Earnings per share was 12.05.
| Revenue | 53.49B |
| Gross Profit | 23.63B |
| Operating Income | 9.42B |
| Pretax Income | 9.95B |
| Net Income | 7.41B |
| EBITDA | 11.01B |
| EBIT | 9.42B |
| Earnings Per Share (EPS) | 12.05 |
Balance Sheet
The company has 6.94 billion in cash and 3.09 billion in debt, giving a net cash position of 3.86 billion.
| Cash & Cash Equivalents | 6.94B |
| Total Debt | 3.09B |
| Net Cash | 3.86B |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 49.37B |
| Book Value Per Share | 80.03 |
| Working Capital | n/a |
Cash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 44.18%, with operating and profit margins of 17.61% and 13.86%.
| Gross Margin | 44.18% |
| Operating Margin | 17.61% |
| Pretax Margin | 18.61% |
| Profit Margin | 13.86% |
| EBITDA Margin | 20.58% |
| EBIT Margin | 17.61% |
| FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 1.00, which amounts to a dividend yield of 0.50%.
| Dividend Per Share | 1.00 |
| Dividend Yield | 0.50% |
| Dividend Growth (YoY) | -20.00% |
| Years of Dividend Growth | 1 |
| Payout Ratio | n/a |
| Buyback Yield | 1.69% |
| Shareholder Yield | 2.19% |
| Earnings Yield | 6.10% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on October 4, 2024. It was a forward split with a ratio of 5.
| Last Split Date | Oct 4, 2024 |
| Split Type | Forward |
| Split Ratio | 5 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |